JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 23, 2008; DOI: 10.1124/jpet.108.140228


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.140228v1
327/1/105    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Stanbouly, S.
Right arrow Articles by Karmazyn, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanbouly, S.
Right arrow Articles by Karmazyn, M.


Received for publication April 21, 2008.
Revised July 22, 2008.
Accepted for publication July 22, 2008.

Sodium Hydrogen Exchange 1 (NHE-1) Regulates Connexin 43 Expression in Cardiomyocytes via Reverse Mode Sodium Calcium Exchange and JNK Dependent Pathways

Seta Stanbouly 1, Lorrie A Kirshenbaum 2, Doug L Jones 1, Morris Karmazyn 1*

1 University of Western Ontario 2 University of Manitoba

* Address correspondence to: E-mail: morris.karmazyn{at}schulich.uwo.ca

Abstract

Connexin 43, the major connexin isoform in gap junctions of cardiac ventricular myocytes, undergoes changes in distribution and expression in cardiac diseases. The Na+-H+ exchanger (NHE-1), a key mediator of hypertrophy and heart failure has been shown to be localized in the cardiomyocyte gap junctional regions, however whether NHE-1 regulates gap junction proteins in the hypertrophied cardiomyocyte is not known. To address this question neonatal rat ventricular myocytes were treated with phenylephrine (PE) for 24 hours to induce hypertrophy. Increased Cx43 expression observed with PE treatment (132.4 ± 6.3 % compared to control; P<0.05) was further significantly augmented by the specific NHE-1 inhibitor EMD87580 (173.2 ± 8.7 % increase compared to control; P<0.05 vs PE), an effect which was mimicked by another NHE-1 inhibitor cariporide. PE-induced hypertrophy was associated with MAPK JNK1/2 activation whereas inhibition of JNK1/2 with either SP60015 or using siRNA significantly increased PE-induced upregulation of Cx43 protein levels. Inhibition of reverse mode Na+-Ca2+ exchange (NCX) with KB-R7943 partially reversed JNK1/2 activation (195.2 ± 21.4 % vs 143.7 ± 14.4 % with KB-R7943; P<0.05) and augmented upregulation of Cx43 protein (121.1 ± 8.3 % vs 215.9 ± 25.6 % with KB-R7943; P<0.05) in the presence of PE. Our results demonstrate that NHE-1 negatively regulates Cx43 protein expression in PE-induced cardiomyocyte hypertrophy via a JNK1/2 dependent pathway which is likely activated by reverse mode NCX activity.


Key words: JNK, Na-H exchange, cardiac myocytes, connexin 43, hypertrophy, reverse mode Na-Ca exchange





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.